Trials / Unknown
UnknownNCT01550029
Targeted Intervention for Bipolar Smokers
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to develop and test a new type of smoking cessation counseling for individuals with bipolar disorder.
Detailed description
All participants will receive the nicotine patch, an FDA-approved smoking cessation medication, in an open-label fashion. In addition to the nicotine patch, participants will be randomized to receive one of the two types of counseling for smoking cessation. Participants will be in the research study for approximately 18 weeks. The total number of study visits is 15.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Counseling/Healthy Lifestyle | A trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting and to help develop knowledge and skills for quitting. Also, the National Cancer Institute's "Clearing the Air" guide to smoking cessation will be given to subjects. Some specific areas of focus for this intervention are developing a better understanding of reasons for smoking and the consequences of tobacco use and identifying ways for establishing a healthier lifestyle. |
| BEHAVIORAL | Counseling/Managing Mood | A trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting smoking and to help develop knowledge and skills for quitting. Also, subjects will receive the National Cancer Institute's "Clearing the Air" guide to smoking cessation. Some specific areas of focus for this intervention are managing negative moods without smoking and overcoming other obstacles to quitting. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2012-03-09
- Last updated
- 2014-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01550029. Inclusion in this directory is not an endorsement.